ISRG
Intuitive SurgicalDAI scenario view
RankAlpha Sentiment CodexPost-earnings T+1AI sentiment snapshot
AI commentary
News tone is negative immediately after Q2 despite strong reported operating results. Social, options, short-interest, employee, analyst-revision, and target-change data are unavailable; missing analyst reaction is not positive evidence and caps confidence.
Evidence flagged
peer set is too generic or lacks enough direct operating comparators
AI events
Stored earnings context flags near-term pressure from da Vinci 5 margins, trade-ins, depreciation, tariffs, freight, semiconductor costs, China and Japan conditions, and GLP-1 effects on bariatric volumes. Recent headlines indicate a sharp post-earnings selloff. [#PR-EARNINGS-2026-07-10]
Q2 revenue reached $2.89 billion, up 19% year over year, with GAAP EPS of $2.29 versus $1.81, combined procedures up approximately 16%, and da Vinci placements of 468 versus 395. The immediate market reaction was negative despite strong reported metrics. [#SEC-8K-2026-07-16]
Q2 da Vinci procedures grew approximately 15%, Ion procedures 36%, the da Vinci installed base increased 12% year over year to 11,710 systems, and the Ion base increased 21% to 1,096. Sustained growth would support recurring instruments, accessories, and leasing revenue. [#SEC-8K-2026-07-16]
Recommendation
No formal recommendation provided.

